JSP 522 Pill — PINK ROUND, 7mm — Levothyroxine

No photo available

Imprint	JSP / 522
Colour	PINK
Shape	ROUND
Size	7
Strength	LEVOTHYROXINE SODIUM 0.2 mg
Dosage form	Tablet
Manufacturer	Amneal Pharmaceuticals NY LLC
NDC	69238-1840
Schedule	—
Availability	Prescription only
Ingredients	LEVOTHYROXINE SODIUM[LEVOTHYROXINE]

What does this imprint mean?

The imprint "JSP 522" is a code stamped or printed on the tablet or capsule by the manufacturer, used to identify the drug, its strength and the maker.

Active ingredient

Levothyroxine

Uses and warnings

BOXED WARNING: "Thyroid hormones should not be used for the treatment of obesity or for weight loss. Larger doses may produce serious or even life threatening manifestations of toxicity." Major Warnings: - Cardiac risks: "Over-treatment may cause an increase in heart rate, cardiac wall thickness, and cardiac contractility and may precipitate angina or arrhythmias"—especially in elderly and cardiac disease patients - Myxedema coma: Do not use oral products; requires intravenous administration - Adrenal crisis: Treat adrenal insufficiency with glucocorticoids before initiating therapy - Narrow therapeutic index: Risk of adverse effects on growth, cardiac function, metabolism, and cognitive function from over/undertreatment - Diabetic control: May "worsen glycemic control and result in increased antidiabetic agent or insulin requirements" - Bone density: Over-replacement increases bone resorption ---

Levothyroxine sodium tablets are indicated for: - Hypothyroidism: "replacement therapy in primary (thyroidal), secondary (pituitary) and tertiary (hypothalamic) congenital or acquired hypothyroidism" - TSH Suppression: "as an adjunct to surgery and radioiodine therapy in the management of thyrotropin-dependent well-differentiated thyroid cancer" Limitations: Not for benign thyroid nodules/nontoxic goiter in iodine-sufficient patients or hypothyroidism during recovery from subacute thyroiditis. ---

Read the full drug profile →